Migraine Drug Ubrogepant Tackles Debilitating Early Symptoms

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity

May 15, 2025 - 00:30
 0
Migraine Drug Ubrogepant Tackles Debilitating Early Symptoms

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent preheadache fatigue and light sensitivity